Mercado Global de Neuropróteses – Tendências e Previsão da Indústria para 2031

Análise e dimensão do mercado de neuropróteses

O mercado das neuropróteses está a avançar com tecnologias de ponta, como interfaces cérebro-máquina e implantes neurais. Estas inovações visam restaurar as funções motoras e a perceção sensorial em doentes com distúrbios neurológicos. Com o aumento dos investimentos em investigação e desenvolvimento, juntamente com a crescente procura de soluções de melhoria da qualidade de vida, o mercado está preparado para um crescimento substancial nos próximos anos.

O tamanho do mercado global de neuropróteses foi avaliado em 24,03 mil milhões de dólares em 2023 e deverá atingir os 69,03 mil milhões de dólares até 2031, com um CAGR de 14,1% durante o período de previsão de 2024 a 2031. Para além dos insights sobre cenários de mercado, tais como mercado valor, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e estrutura regulatória.

Âmbito do relatório e segmentação de mercado

Definição de mercado

Neuroprosthetics involves the development and application of devices that interface with the nervous system to restore lost sensory or motor functions. These devices can range from brain implants to artificial limbs, aiming to enhance the quality of life for individuals with disabilities. By bridging the gap between biology and technology, neuroprosthetics enables direct communication between the brain and external devices, offering promising avenues for rehabilitation and functional restoration.            

Neuroprosthetics Market Dynamics

Drivers

• Rising Prevalence of Neurological Disorders

The rising prevalence of neurological disorders such as Parkinson's disease and epilepsy has significantly expanded the patient base seeking neuroprosthetic solutions. For instance, Parkinson's disease affects over 10 million people worldwide, driving demand for deep brain stimulation devices that mitigate symptoms. This trend fuels innovation and investment in neuroprosthetics, aiming to restore lost motor functions and improve the quality of life for affected individuals, thereby propelling market growth in the neuroprosthetics sector.

• Increasing Acceptance of Brain-Computer Interfaces (BCIs)

The increasing acceptance of Brain-Computer Interfaces (BCIs) among paralyzed individuals for communication and control purposes is significantly expanding the neuroprosthetics market. For instance, developments in BCIs have enabled paralyzed patients to communicate through direct brain signals, enhancing their quality of life. This growing adoption showcases BCIs as transformative tools beyond motor function restoration, driving demand for advanced neuroprosthetic solutions that integrate seamlessly with neural interfaces.

Opportunities

• Advancements in Neural Interface Technology

Advancements in neural interface technology, including enhanced electrode designs and biocompatible materials, are pivotal in driving the neuroprosthetics market. For instance, flexible and micro-scale electrodes improve neural signal detection accuracy and reduce tissue damage, extending device longevity. These innovations enable more precise control and functionality in neuroprosthetic devices, fostering opportunities for developing sophisticated solutions that cater to diverse neurological conditions, thereby expanding the market's potential and application scope.

• Rising Demand for Minimally Invasive Procedures

The rising demand for minimally invasive procedures is catalyzing innovation in neuroprosthetics, fostering the development of less invasive implantation techniques and devices. For instance, advancements in surgical robotics have enabled precise, minimally invasive implantation of neural interfaces, reducing recovery times and complications for patients. This trend not only enhances patient outcomes but also expands market opportunities by appealing to healthcare providers and patients seeking safer and more effective treatment options in neuroprosthetics.

Restraints/Challenges

• Limited Long-term Durability and Reliability

The neuroprosthetics market faces significant challenges in maintaining long-term functionality and durability. Issues such as material degradation, neural adaptation, and mechanical wear contribute to reduced device lifespan, necessitating frequent maintenance or replacement. These factors escalate costs and inconvenience for patients, thereby hindering market growth and adoption. Addressing these durability concerns is crucial to overcoming barriers to the widespread acceptance and use of neuroprosthetic technologies. 

• Integration and Compatibility Issues

Integration and compatibility issues in neuroprosthetic devices hinder market growth due to complexities in aligning with diverse patient anatomies and physiological nuances. Challenges include minimizing tissue damage, optimizing long-term performance, and mitigating adverse effects, which collectively impede seamless integration into neural structures. These technical hurdles necessitate rigorous testing and customization efforts, contributing to delays in adoption and limiting widespread market acceptance. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In December 2022, Saskatchewan's Ministry of Health and the Saskatchewan Health Authority launched an expanded Cochlear Implant Program, offering subsidized replacements for external sound processors. Individuals contribute USD 840 per implant, with the Ministry covering the remainder (USD 8,000 to USD 12,000). This initiative aims to enhance accessibility to auditory devices for those in need across the province
• In October 2022, Axoft, a neurotechnology firm, introduced a brain-machine interface (BMI) targeting neurological disorders. This FDA breakthrough device involves neural implants, with an initial USD 8 million in funding for FDA studies and prototype scaling. The innovation seeks to advance treatment efficacy and patient outcomes through advanced neurotechnology solutions
• In July 2021, Researchers at US San Francisco developed a groundbreaking "speech neuroprosthesis." This device enables individuals with severe paralysis to communicate in sentences by translating brain signals directly into spoken words displayed as text on a screen. The innovation represents a significant advancement in assistive technology, enhancing communication and quality of life for paralyzed individuals
• In April 2021, Houston Methodist and Rice University launched a collaborative center for Translational Neural Prosthetics. This partnership focuses on neuroprosthetics research aimed at restoring brain function post-disease or injury. The initiative integrates clinical expertise from Houston Methodist with research capabilities from Rice University, aiming to accelerate innovations in neural prosthetics for neurological rehabilitation

Neuroprosthetics Market Scope

The market is segmented on the basis of type, technique, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Output Neural Prosthetics
  • Cognitive Prosthetics
  • Motor Prosthetics
• Input Neural Prosthetics
  • Cochlear Implant
  • Visual Prosthetics

 Technique

• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Spinal Cord Stimulation
• Sacral Nerve Stimulation

 Application

• Motor Neuron Disorders
  • Parkinson's disease
  • Epilepsy
• Physiological Disorders
  • Auditory Disorders
  • Ophthalmic Disorders
  • Neurocardiac Disorders
  • Over Active Bladder Syndrome
• Cognitive Disorders
  • Alzheimer's disease
  • Severe Depression
  • Paralysis

 End User

• Hospitals
• Clinics

Neuroprosthetics Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, type, technique, application and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Espera-se que a América do Norte domine o mercado das neuropróteses devido ao robusto financiamento governamental e privado, juntamente com instalações de saúde bem estabelecidas. Estes fatores facilitam a investigação avançada, o desenvolvimento e a adoção de tecnologias neuroprotéticas, posicionando a região na vanguarda da inovação e do crescimento do mercado na área.

Estima-se que a Ásia-Pacífico testemunhe um elevado crescimento no mercado das neuropróteses. Este aumento é impulsionado pelos esforços para reduzir os custos de fabrico de implantes, pelo aumento dos investimentos dos participantes da indústria e pela crescente consciencialização dos doentes. Estes fatores contribuem coletivamente para uma perspetiva promissora de avanços e adoção de tecnologias neuroprotéticas na região.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Crescimento da infraestrutura de saúde Base instalada e penetração de novas tecnologias

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do cenário competitivo e da quota de mercado das neuropróteses

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Corporação Científica de Boston (EUA)
• Zimmer Biomet (EUA)
• (Austrália)
• Medtronic (EUA)
• NDI Medical, LLC (EUA)
• (EUA)
• NEVRO CORP (EUA)
• Abbott (EUA)
• Sonova (Suíça)
• CorTec GmbH (Alemanha)
• Neuro Device Group SA (Polónia)
• LivaNova PLC (Reino Unido)
• Electrónica Médica MED-EL (Áustria)

SKU-10631